CLINICAL EFFECTS OF ORAL MELATONIN IN HIGH-RISK CRITICALLY ILL

被引：0
|
作者：
Mistraletti, G. [1 ]
Tozzi, M. [1 ]
Miori, S. [1 ]
Taverna, M. [1 ]
Cerri, B. [1 ]
Galluccio, I. [1 ]
Umbrello, M. [1 ]
Salini, S. [2 ]
Morabito, A. [3 ]
Fraschini, F. [4 ]
Iapichino, G. [1 ]
机构：
[1] Univ Milan, AO San Paolo Dipartimento Anestesiol & Terapia In, Milan, Italy
[2] Univ Milan, Dipartimento Sci Econ Aziendali & Stat, Milan, Italy
[3] Univ Milan, Cattedra Biostat, Dipartimento Med Chirurgia & Odontoiatria, Milan, Italy
[4] Univ Milan, AO San Paolo Dipartimento Farmacol Chemioterapia, Milan, Italy
来源：
INTENSIVE CARE MEDICINE | 2011年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
0994
引用
收藏
页码：S254 / S254
页数：1
相关论文
共 50 条
  • [31] Clinical and Pathological Features of Oral Cancer in a High-Risk Community in Vietnam
    Do, Thao Thi
    Bui, Loc Ngoc Vinh
    Nguyen, Lam
    Le, Lam Nguyen
    Tran, Dan Thi Phuong
    JOURNAL OF MAXILLOFACIAL & ORAL SURGERY, 2025, 24 (01): : 241 - 245
  • [32] CLINICAL AND PHARMACOKINETIC EVALUATION OF ORAL ACETAMINOPHEN ABSORPTION IN CRITICALLY ILL PATIENTS
    Rhoades, Abby
    Droege, Molly
    Droege, Chris
    Welch, Megan
    Ernst, Neil
    Keegan, Shaun
    Mueller, Eric
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [33] Melatonin: possible implications for the postoperative and critically ill patient
    Richard S. Bourne
    Gary H. Mills
    Intensive Care Medicine, 2006, 32 : 371 - 379
  • [34] Minimally-invasive tracheostomy (MIT): A care bundle for safety improvement in high-risk critically ill patients
    Harrer, Dennis Christoph
    Mester, Patricia
    Lang, Clara-Larissa
    Elger, Tanja
    Seefeldt, Tobias
    Waechter, Lorenz
    Doenz, Judith
    Doblinger, Nina
    Huss, Muriel
    Athanasoulas, Georgios
    Krauss, Lea U.
    Heymer, Johannes
    Herr, Wolfgang
    Schilling, Tobias
    Schmid, Stephan
    Mueller, Martina
    Pavel, Vlad
    JOURNAL OF CLINICAL ANESTHESIA, 2024, 99
  • [35] Reply to comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients"
    Pittet, D
    Garbino, J
    Hugonnet, S
    Romand, J
    Lew, DP
    INTENSIVE CARE MEDICINE, 2003, 29 (07) : 1194 - 1195
  • [36] Reply to comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients"
    Didier Pittet
    Jorge Garbino
    Stéphane Hugonnet
    Jacques Romand
    Daniel P. Lew
    Intensive Care Medicine, 2003, 29 : 1194 - 1195
  • [37] PROSPECTIVE RANDOMIZED EVALUATION OF INDWELLING RADIAL VS FEMORAL ARTERIAL CATHETERS IN HIGH-RISK CRITICALLY ILL PATIENTS
    THOMAS, F
    PARKER, J
    BURKE, J
    ORME, J
    GARDNER, R
    CLEMMER, T
    HILL, G
    CRITICAL CARE MEDICINE, 1982, 10 (03) : 226 - 226
  • [38] Pharmacokinetics of orally administered melatonin in critically ill patients
    B Moroni
    G Mistraletti
    RJ Reiter
    R Esposti
    E D'Angelo
    P Formenti
    D Palmisano
    E Borotto
    P Di Mauro
    G Iapichino
    Critical Care, 14 (Suppl 1):
  • [39] High-Risk Percutaneous Coronary Intervention in Public Reporting States: the Evidence, Exclusion of Critically Ill Patients, and Implications
    Wadhera R.K.
    Anderson J.D.
    Yeh R.W.
    Current Heart Failure Reports, 2017, 14 (6) : 514 - 518
  • [40] Pharmacokinetics of orally administered melatonin in critically ill patients
    Mistraletti, Giovanni
    Sabbatini, Giovanni
    Taverna, Martina
    Figini, Maria Adele
    Umbrello, Michele
    Magni, Paolo
    Ruscica, Massimiliano
    Dozio, Elena
    Esposti, Roberto
    DeMartini, Germana
    Fraschini, Franco
    Rezzani, Rita
    Reiter, Russel J.
    Iapichino, Gaetano
    JOURNAL OF PINEAL RESEARCH, 2010, 48 (02) : 142 - 147
12345